Posted September 28, 2018
In February 2018, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to re-recommend the live virus nasal spray influenza vaccine, FluMist, for the 2018-19 “flu season” after a two-year hiatus.1 Read more.